Villani G - Search Results

1

Phase II trial of infusional cyclophosphamide, idarubicin, and etoposide in poor prognosis non-Hodgkin's lymphoma.

Salman H, Perez A, Sparano JA, Ratech H, Negassa A, Hopkins U, Villani G, Fuks J, Wiernik PH. Salman H, et al. Among authors: villani g. Am J Clin Oncol. 2003 Aug;26(4):338-43. doi: 10.1097/01.COC.0000020651.11284.DE. Am J Clin Oncol. 2003. PMID: 12902881 Clinical Trial.

2

A novel second line chemotherapy treatment of recurrent thymoma.

Jan N, Villani GM, Trambert J, Fehmian C, Sood B, Wiernik PH. Jan N, et al. Among authors: villani gm. Med Oncol. 1997 Sep-Dec;14(3-4):163-8. doi: 10.1007/BF02989645. Med Oncol. 1997. PMID: 9468040

3

Combination chemotherapy using vincristine, adriamycin, cyclophosphamide (VAC) alternating with ifosfamide and etoposide (IE) for advanced soft tissue sarcomas: a phase II study.

Palumbo R, Palmeri S, Gatti C, Villani G, Cesca A, Toma S. Palumbo R, et al. Among authors: villani g. Oncol Rep. 1998 Jan-Feb;5(1):69-72. doi: 10.3892/or.5.1.69. Oncol Rep. 1998. PMID: 9458296 Clinical Trial.

4

Dose-intensive first-line chemotherapy with epirubicin and continuous infusion ifosfamide in adult patients with advanced soft tissue sarcomas: a phase II study.

Palumbo R, Neumaier C, Cosso M, Bertero G, Raffo P, Spadini N, Valente S, Villani G, Pastorino M, Toma S. Palumbo R, et al. Among authors: villani g. Eur J Cancer. 1999 Jan;35(1):66-72. doi: 10.1016/s0959-8049(98)00293-7. Eur J Cancer. 1999. PMID: 10211090 Clinical Trial.

5

Clinical Cancer Advances 2016: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology.

Dizon DS, Krilov L, Cohen E, Gangadhar T, Ganz PA, Hensing TA, Hunger S, Krishnamurthi SS, Lassman AB, Markham MJ, Mayer E, Neuss M, Pal SK, Richardson LC, Schilsky R, Schwartz GK, Spriggs DR, Villalona-Calero MA, Villani G, Masters G. Dizon DS, et al. Among authors: villani g. J Clin Oncol. 2016 Mar 20;34(9):987-1011. doi: 10.1200/JCO.2015.65.8427. Epub 2016 Feb 4. J Clin Oncol. 2016. PMID: 26846975 Free PMC article. No abstract available.

6

Phase II study of continuous-infusion high-dose ifosfamide in advanced and/or metastatic pretreated soft tissue sarcomas.

Palumbo R, Palmeri S, Antimi M, Gatti C, Raffo P, Villani G, Toma S. Palumbo R, et al. Among authors: villani g. Ann Oncol. 1997 Nov;8(11):1159-62. doi: 10.1023/a:1008279426654. Ann Oncol. 1997. PMID: 9426338 Free article. Clinical Trial.

7

Liposomal doxorubicin (Caelyx) in advanced pretreated soft tissue sarcomas: a phase II study of the Italian Sarcoma Group (ISG).

Toma S, Tucci A, Villani G, Carteni G, Spadini N, Palumbo R. Toma S, et al. Among authors: villani g. Anticancer Res. 2000 Jan-Feb;20(1B):485-91. Anticancer Res. 2000. PMID: 10769710 Clinical Trial.

8

Risk of having BRCA1 mutation in high-risk women with triple-negative breast cancer: a meta-analysis.

Tun NM, Villani G, Ong K, Yoe L, Bo ZM. Tun NM, et al. Among authors: villani g. Clin Genet. 2014 Jan;85(1):43-8. doi: 10.1111/cge.12270. Epub 2013 Oct 3. Clin Genet. 2014. PMID: 24000781

9

American Society of Clinical Oncology policy statement on medicaid reform.

Polite BN, Griggs JJ, Moy B, Lathan C, duPont NC, Villani G, Wong SL, Halpern MT. Polite BN, et al. Among authors: villani g. J Clin Oncol. 2014 Dec 20;32(36):4162-7. doi: 10.1200/JCO.2014.56.3452. Epub 2014 Nov 17. J Clin Oncol. 2014. PMID: 25403206 Free PMC article. No abstract available.

10

Potential of the patient protection and affordable care act to reduce cancer care disparities.

Villani G. Villani G. J Oncol Pract. 2011 Sep;7(5):340-1. doi: 10.1200/JOP.2011.000400. J Oncol Pract. 2011. PMID: 22211135 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

398 results

Search Page

Filters